Koss-Olinger Consulting »

Intellia Therapeutics shares owned by Koss-Olinger Consulting

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Koss-Olinger Consulting from 13F filings

Historical chart of Koss-Olinger Consulting investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Koss-Olinger Consulting consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Koss-Olinger Consulting

Quarter filed Position value Share count Share price at filing
2025-09-30 $94k 10k 9.40
2025-06-30 $94k 10k 9.38
2021-06-30 $1.3M 8.0k 161.88
2021-03-31 $642k 8.0k 80.25

More positions owned by Koss-Olinger Consulting

Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Pimco Etf Tr Active Bd Etf (BOND)
J P Morgan Exchange Traded F Diversfd Eqt Etf (JPSE)
Spdr Series Trust Portfolio S&p400 (SPMD)
Ishares Tr Broad Usd High (USHY)
Vanguard Bd Index Fds Long Term Bond (BLV)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
Spdr Series Trust Prtflo S&p500 Vl (SPYV)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr S&p 500 Val Etf (IVE)
Pacer Fds Tr Trendp Us Lar Cp (PTLC)
Tesla Motors (TSLA)
Spdr Series Trust S&p 500 Esg Etf (EFIV)
Ishares Tr Intrm Gov Cr Etf (GVI)
Vaneck Etf Trust Emerging Mrkt Hi (HYEM)

View all positions for Koss-Olinger Consulting

Top funds holding Intellia Therapeutics

ARK Investment Management
Vanguard Group
BlackRock
Contrarius Group Holdings
State Street Corporation
Goldman Sachs Group
Morgan Stanley
Regeneron Pharmaceuticals
Baker Bros. Advisors
Geode Capital Management
Two Sigma Investments
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
D. E. Shaw & Co
Two Sigma Advisers

View all funds holding Intellia Therapeutics